Table of Contents
ISRN Gastroenterology
Volume 2011, Article ID 976019, 4 pages
Research Article

The Effect of Hibiscus Sabdariffa on Lipid Profile, Creatinine, and Serum Electrolytes: A Randomized Clinical Trial

1Department of Cardiology, Shariati Hospital, Tehran University of Medical Sciences, Tehran 14114, Iran
2Medical Student Research Center, School of Medicine, Tehran University of Medical Sciences, Tehran 14114, Iran
3Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Kargar st., Tehran 14114, Iran
4Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran 14114, Iran

Received 8 September 2010; Accepted 21 October 2010

Academic Editor: A. K. Rishi

Copyright © 2011 Abbas Mohagheghi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Background. Hibiscus Sabdariffa L. (HS), a member of malvaceae family, is a medicinal plant with a worldwide fame. Its effect on reducing serum lipids is mentioned in several studies. The purpose of this study was to assess the efficacy of this plant in reducing the serum's lipids in hypertensive patients. Materials and Methods. Ninety hypertensive patients were randomly assigned to receive Hibiscus Sabdariffa (HS) tea or black tea for 15 days. The patients were asked to drink the tea within 20 minutes following its preparation. This process had to be repeated two times, daily. Patient's FBS and lipid profile were collected at the first visit day (day 0) and on the day 30. Results. There was no significant differences between pre and post experiment values within the two groups. An upward trend in total cholesterol, HDL, and LDL cholesterol was evident in both groups. The increase in total and HDL cholesterol in both groups relative to their initial values were significant. Conclusion. Hibiscus Sabdariffa is probably a safe medicinal plant. No significant harmful changes in cholesterol, triglyceride, BUN, serum creatinine, Na and K levels were observed within 15 days after the discontinuation of the medication.